A pharmacogenomic analysis using L1000CDS2 identifies BX-795 as a potential anticancer drug for primary pancreatic ductal adenocarcinoma cellsEun A Choi, Suhwan Chang, Yeon-Sook Choi et al.|Cancer Letters|2019Cited by 18